COVID-19 Delta Variant Co-Infection Mimicking COVID-19 ARDS

The Delta variant of COVID-19 has been associated with severe disease causing a surge in the second half of 2021. Atypical pathogens can be present in those in particular with severe ARDS and can contribute to excess morbidity and mortality. We must maintain a high level of suspicion for these patho...

Full description

Saved in:
Bibliographic Details
Main Authors: James Crosby DO (Author), Sarah Semon MD (Author), Subramanya Shyam Ganti MD, MBBS (Author), Enid Klauber-Choephel MD (Author), James Abraham MD (Author)
Format: Book
Published: SAGE Publishing, 2022-10-01T00:00:00Z.
Subjects:
Online Access:Connect to this object online.
Tags: Add Tag
No Tags, Be the first to tag this record!

MARC

LEADER 00000 am a22000003u 4500
001 doaj_bc90b3cd7dc044d8be5279a2a6e824f2
042 |a dc 
100 1 0 |a James Crosby DO  |e author 
700 1 0 |a Sarah Semon MD  |e author 
700 1 0 |a Subramanya Shyam Ganti MD, MBBS  |e author 
700 1 0 |a Enid Klauber-Choephel MD  |e author 
700 1 0 |a James Abraham MD  |e author 
245 0 0 |a  COVID-19 Delta Variant Co-Infection Mimicking COVID-19 ARDS 
260 |b SAGE Publishing,   |c 2022-10-01T00:00:00Z. 
500 |a 2324-7096 
500 |a 10.1177/23247096221129925 
520 |a The Delta variant of COVID-19 has been associated with severe disease causing a surge in the second half of 2021. Atypical pathogens can be present in those in particular with severe ARDS and can contribute to excess morbidity and mortality. We must maintain a high level of suspicion for these pathogens as this can present an opportunity to dramatically improve the prognosis of a patient with COVID-19 ARDS. However, lend caution to Mycoplasma IgM serology as this can be a false-positive. If suspicion remains high for Mycoplasma pneumoniae infection, sputum polymerase chain reaction (PCR) for M pneumoniae is the gold standard for diagnosis. We present the case of a 42-year-old female with COVID-19 Delta variant presumed ARDS who had co-infection with M pneumoniae confirmed by endotracheal sputum aspirate PCR with rapidly improving oxygenation and extubation within 4 days of effective antibiotic therapy. 
546 |a EN 
690 |a Medicine (General) 
690 |a R5-920 
690 |a Pathology 
690 |a RB1-214 
655 7 |a article  |2 local 
786 0 |n Journal of Investigative Medicine High Impact Case Reports, Vol 10 (2022) 
787 0 |n https://doi.org/10.1177/23247096221129925 
787 0 |n https://doaj.org/toc/2324-7096 
856 4 1 |u https://doaj.org/article/bc90b3cd7dc044d8be5279a2a6e824f2  |z Connect to this object online.